IM Cannabis

Company Overview

Snapshot

Founded in January 2008, IM Cannabis operates with 11–50 employees and has raised a total of $68 million across 14 funding rounds. The company went public on NASDAQ in March 2021, marking a significant milestone in its growth trajectory.

Business overview

IM Cannabis is an international medical cannabis company focused on providing premium cannabis products to patients in Israel and Germany, two key medical cannabis markets. The company utilizes a data-driven approach and a globally sourced product supply chain to support its operations within the Health Tech & Life Sciences sector, specifically in Pharma & Medical Biotechnology and Medical Cannabis.

Strategic signal

In March 2026, IM Cannabis announced a strategic entry into the cyber drone interception and satellite intelligence markets by signing a non-binding agreement to acquire a 51% stake in Blackaxe Technologies. This move signals a significant strategic pivot for the company, diversifying its operations beyond medical cannabis and indicating a potential shift towards high-tech defense and intelligence sectors, which could open new revenue streams and investor interest.

Company Intelligence Q&A

What was IM Cannabis's revenue growth in Germany in 2025?

IM Cannabis reported over 134% growth in Germany, contributing to a total revenue of C$54.7 million in 2025, as announced in March 2026.

What was IM Cannabis's most recent financing activity?

In June 2026, IM Cannabis raised US$225,000 of gross proceeds in convertible note financing.

When did IM Cannabis report its First Quarter 2026 financial results?

IM Cannabis Corp. announced its First Quarter 2026 financial results on May 13, 2026.

What strategic acquisition did IM Cannabis announce in March 2026?

In March 2026, IM Cannabis announced a strategic entry into the cyber drone interception and satellite intelligence markets by signing a non-binding agreement to acquire 51% of Blackaxe Technologies.

What significant operational change did IM Cannabis announce in June 2026?

In June 2026, IM Cannabis Corp. entered into a Letter of Intent to sell its European activities, expecting to significantly reduce debt by CAD$10.5 million.